Table 4. Risk factors for all-cause mortality and MACE by multivariate Cox analysis.
All-cause mortality |
MACE |
||||
Variables | HR (95% CI) | P-value | Variables | HR (95% CI) | P-value |
D-dimer ≥ 0.84 mg/L (vs. < 0.84 mg/L) | 2.315 (1.570–3.414) | < 0.001 | D-dimer | 1.256 (1.058–1.490) | 0.009 |
SBP | 0.984 (0.972–0.996) | 0.010 | SBP | 0.984 (0.973–0.995) | 0.003 |
LVEF | 0.942 (0.909–0.976) | 0.001 | LVEF | 0.943 (0.912–0.976) | 0.001 |
Beta blockers use | 0.515 (0.327–0.812) | 0.004 | ACEIs/ARBs use | 0.627 (0.447–0.879) | 0.007 |
VT/VF occurrence | 3.309 (2.276–4.811) | < 0.001 |
ACEIs: angiotensin-converting enzyme inhibitors; ARBs: angiotensin receptors blockers; LVEF: left ventricular ejection fraction; MACE: major adverse cardiovascular event; SBP: systolic blood pressure; VF: ventricular fibrillation; VT: ventricular tachycardia.